CD2 and diabetic kidney disease: (19) showed that the mRNA expression of urinary podocyte injury markers (synaptopodin, podocalyxin, CD2-AP, α-actin4 and podocin) was significantly increased, and negatively correlated with eGFR, in DKD patients compared with those of healthy controls.